Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8966) 8966
Newsletter (224) 224
Newspaper Article (23) 23
Book Chapter (13) 13
Magazine Article (10) 10
Book / eBook (7) 7
Publication (2) 2
Dissertation (1) 1
Reference (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (7119) 7119
life sciences & biomedicine (6891) 6891
humans (6718) 6718
male (3978) 3978
hypoglycemic agents - therapeutic use (3662) 3662
diabetes mellitus, type 2 - drug therapy (3457) 3457
pharmacology & pharmacy (3075) 3075
animals (2951) 2951
hypoglycemic agents - pharmacokinetics (2949) 2949
hypoglycemic agents - administration & dosage (2928) 2928
female (2829) 2829
diabetes (2742) 2742
biological and medical sciences (2345) 2345
type 2 diabetes (2339) 2339
hypoglycemic agents - pharmacology (2320) 2320
medical sciences (2258) 2258
endocrinology & metabolism (2166) 2166
insulin (2083) 2083
middle aged (1885) 1885
adult (1836) 1836
hypoglycemic agents (1717) 1717
hypoglycemic agents - adverse effects (1707) 1707
pharmacology. drug treatments (1599) 1599
blood glucose - metabolism (1488) 1488
glucose (1481) 1481
rats (1317) 1317
aged (1280) 1280
insulin - administration & dosage (1252) 1252
blood glucose - drug effects (1216) 1216
diabetes mellitus (1117) 1117
diabetes mellitus, type 2 - blood (1082) 1082
insulin - therapeutic use (1081) 1081
diabetes therapy (1032) 1032
treatment outcome (1015) 1015
analysis (984) 984
diabetes mellitus, type 1 - drug therapy (932) 932
research (926) 926
drug therapy (923) 923
care and treatment (891) 891
administration, oral (878) 878
metformin (868) 868
insulin - pharmacokinetics (830) 830
hypoglycemic agents - chemistry (820) 820
dextrose (805) 805
pharmacokinetics (805) 805
endocrinopathies (777) 777
dose-response relationship, drug (761) 761
mice (750) 750
endocrine pancreas. apud cells (748) 748
diabetes. impaired glucose tolerance (747) 747
insulin - analogs & derivatives (746) 746
internal medicine (708) 708
chemistry (690) 690
hypoglycemic agents - blood (690) 690
physical sciences (679) 679
medicine & public health (647) 647
cross-over studies (643) 643
insulin resistance (640) 640
blood glucose - analysis (639) 639
drug therapy, combination (635) 635
insulin - blood (629) 629
etiopathogenesis. screening. investigations. target tissue resistance (626) 626
diabetes mellitus, type 2 - metabolism (621) 621
diabetes mellitus - drug therapy (608) 608
double-blind method (603) 603
hypoglycemia (598) 598
glycated hemoglobin a - metabolism (584) 584
hypoglycemia - chemically induced (581) 581
drug interactions (574) 574
metformin - therapeutic use (567) 567
abridged index medicus (561) 561
drug administration schedule (560) 560
area under curve (558) 558
dosage and administration (557) 557
adolescent (555) 555
clinical trials (541) 541
pharmacology/toxicology (541) 541
general & internal medicine (535) 535
health aspects (533) 533
hyperglycemia (523) 523
blood sugar (520) 520
medicine, general & internal (515) 515
rats, sprague-dawley (511) 511
rats, wistar (511) 511
general and cellular metabolism. vitamins (497) 497
risk factors (495) 495
young adult (489) 489
type 2 diabetes mellitus (482) 482
pharmacology (477) 477
diabetes mellitus, experimental - drug therapy (468) 468
chemistry, medicinal (461) 461
insulin - metabolism (452) 452
time factors (451) 451
physiological aspects (450) 450
general pharmacology (432) 432
glucose metabolism (431) 431
metformin - pharmacokinetics (429) 429
biochemistry & molecular biology (423) 423
type 1 diabetes (421) 421
biological availability (418) 418
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9065) 9065
Japanese (99) 99
German (79) 79
French (33) 33
Chinese (32) 32
Spanish (28) 28
Russian (17) 17
Portuguese (11) 11
Italian (8) 8
Czech (7) 7
Danish (7) 7
Dutch (6) 6
Hungarian (6) 6
Polish (6) 6
Norwegian (4) 4
Romanian (3) 3
Croatian (1) 1
Hebrew (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Effects of Obesity on Pharmacokinetics: Implications for Drug Therapy
by Cheymol G
09/2000, Volume 39, Issue 3, 17
Beta adrenoceptor antagonists, pharmacokinetics | Bisoprolol, pharmacokinetics | Propranolol, pharmacokinetics | Gentamicin, pharmacokinetics | Dexfenfluramine, pharmacokinetics | Clinical pharmacokinetics | Nicotine, pharmacokinetics | Sotalol, pharmacokinetics | Antineoplastics, pharmacokinetics | Remifentanil, pharmacokinetics | Antihyperglycaemics, pharmacokinetics | Vecuronium bromide, pharmacokinetics | Theophylline, pharmacokinetics | Phenytoin, pharmacokinetics | Antibacterials, pharmacokinetics | Anaesthetics, pharmacokinetics | Doxorubicin, pharmacokinetics | Propofol, pharmacokinetics | Rocuronium bromide, pharmacokinetics | Anticonvulsants, pharmacokinetics | Carbamazepine, pharmacokinetics | Nebivolol, pharmacokinetics | Obesity | Sufentanil, pharmacokinetics | Vancomycin, pharmacokinetics | Anorectics, pharmacokinetics | Neuropsychotherapeutics, pharmacokinetics | Caffeine, pharmacokinetics | Interferon alpha, pharmacokinetics | Neuromuscular blocking agents, pharmacokinetics | Antifungals, pharmacokinetics | Cyclophosphamide, pharmacokinetics | Xanthines, pharmacokinetics | Ciprofloxacin, pharmacokinetics | General anaesthesia | Glibenclamide, pharmacokinetics | Labetalol, pharmacokinetics | Busulfan, pharmacokinetics | Glipizide, pharmacokinetics | Ifosfamide, pharmacokinetics | Lithium, pharmacokinetics | Opioids, pharmacokinetics | Carboplatin, pharmacokinetics | Phenazone, pharmacokinetics | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | General pharmacology | Pharmacology. Drug treatments | Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions | Biological and medical sciences | Metabolic diseases | Medical sciences | Adrenergic beta-Antagonists - pharmacokinetics | Anesthetics - pharmacokinetics | Anticonvulsants - pharmacokinetics | Hypoglycemic Agents - pharmacokinetics | Obesity - drug therapy | Antifungal Agents - pharmacokinetics | Humans | Anti-Bacterial Agents - pharmacokinetics | Antineoplastic Agents - pharmacokinetics | Obesity - metabolism | Index Medicus
Book Review
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Clinical Pharmacokinetics of Metformin
by Graham, Garry G and Punt, Jeroen and Arora, Manit and Day, Richard O and Doogue, Matthew P and Duong, Janna and Furlong, Timothy J and Greenfield, Jerry R and Greenup, Louise C and Kirkpatrick, Carl M and Ray, John E and Timmins, Peter and Williams, Kenneth M
Clinical pharmacokinetics, ISSN 0312-5963, 2/2011, Volume 50, Issue 2, pp. 81 - 98
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions | Hypoglycemic Agents - therapeutic use | Hypoglycemic Agents - pharmacokinetics | Injections, Intravenous | Metformin - therapeutic use | Blood Glucose - analysis | Metformin - pharmacokinetics | Organic Cation Transport Proteins - metabolism | Administration, Oral | Humans | Half-Life | Biological Availability | Renal Insufficiency - metabolism | Diabetes Mellitus, Type 2 - metabolism | Hypoglycemic Agents - administration & dosage | Polymorphism, Single Nucleotide | Metformin - administration & dosage | Diabetes Mellitus, Type 2 - drug therapy | Organic Cation Transport Proteins - genetics | Complications and side effects | Dosage and administration | Metformin | Research | Properties | Pharmacokinetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text p‐Coumaric acid and its conjugates: dietary sources, pharmacokinetic properties and biological activities
by Pei, Kehan and Ou, Juanying and Huang, Junqing and Ou, Shiyi
Journal of the science of food and agriculture, ISSN 0022-5142, 07/2016, Volume 96, Issue 9, pp. 2952 - 2962
p‐coumaric acid | derivatives | anti‐microbial activity | absorption | diabetes | Anti-microbial activity | Absorption | Derivatives | Diabetes | p-coumaric acid | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Applied | Food Science & Technology | Agriculture, Multidisciplinary | Agriculture | Science & Technology | Antioxidants - chemistry | Coumaric Acids - chemistry | Anti-Infective Agents - metabolism | Hypoglycemic Agents - metabolism | Antioxidants - metabolism | Humans | Diet, Healthy | Intestinal Absorption | Anti-Infective Agents - chemistry | Antineoplastic Agents, Phytogenic - metabolism | Coumaric Acids - adverse effects | Dietary Supplements - adverse effects | Antineoplastic Agents, Phytogenic - therapeutic use | Antineoplastic Agents, Phytogenic - adverse effects | Coumaric Acids - therapeutic use | Hypoglycemic Agents - therapeutic use | Plants, Edible - metabolism | Plants, Medicinal - chemistry | Anti-Infective Agents - adverse effects | Plants, Edible - chemistry | Agaricales - metabolism | Coumaric Acids - metabolism | Anti-Infective Agents - therapeutic use | Antineoplastic Agents, Phytogenic - chemistry | Hypoglycemic Agents - chemistry | Renal Elimination | Secondary Metabolism | Antioxidants - therapeutic use | Food Preservatives - metabolism | Animals | Food Preservatives - chemistry | Propionates | Antioxidants - adverse effects | Dysbiosis - prevention & control | Food Preservatives - adverse effects | Hypoglycemic Agents - adverse effects | Plants, Medicinal - metabolism | Agaricales - chemistry | Antioxidants | Phenols | Pharmacology | Kinetics | Bioavailability | Index Medicus | Conjugates | Toxicity | Biocompatibility | Mice | Agglomeration | Conjugation | Biological activity
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Metformin pathways: pharmacokinetics and pharmacodynamics
by Gong, Li and Goswami, Srijib and Giacomini, Kathleen M and Altman, Russ B and Klein, Teri E
Pharmacogenetics and genomics, ISSN 1744-6872, 11/2012, Volume 22, Issue 11, pp. 820 - 827
type 2 diabetes | OCT1 | OCT2 | pharmacokinetics | metformin | diabetes mellitus | pharmacogenomic | AMP-activated protein kinase | multidrug and toxin extrusion 1 | pathway,pharmacodynamics | Pharmacology & Pharmacy | Genetics & Heredity | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Diabetes. Impaired glucose tolerance | General pharmacology | Pharmacology. Drug treatments | Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Hypoglycemic Agents - pharmacokinetics | Metformin - pharmacokinetics | Humans | Metformin - pharmacology | Diabetes Mellitus, Type 2 - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - pharmacology | Index Medicus | pharmacodynamics | pathway
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Metformin and other antidiabetic agents in renal failure patients
by Lalau, Jean-Daniel and Arnouts, Paul and Sharif, Adnan and De Broe, Marc E
Kidney international, ISSN 0085-2538, 02/2015, Volume 87, Issue 2, pp. 308 - 322
Type 2 diabetes | lactic acidosis | pharmacokinetics | metformin | chronic kidney disease | antidiabetic agents | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Metformin - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Diabetic Nephropathies - drug therapy | Glycoside Hydrolase Inhibitors - therapeutic use | Incretins - pharmacokinetics | Diabetes Mellitus, Type 2 - metabolism | Metformin - adverse effects | Thiazolidinediones - pharmacokinetics | Thiazolidinediones - therapeutic use | Glycoside Hydrolase Inhibitors - pharmacokinetics | Acidosis, Lactic - etiology | Renal Insufficiency - drug therapy | Sulfonylurea Compounds - pharmacokinetics | Hypoglycemic Agents - therapeutic use | Hypoglycemic Agents - pharmacokinetics | Metformin - pharmacokinetics | Diabetic Nephropathies - metabolism | Sulfonylurea Compounds - therapeutic use | Renal Insufficiency - metabolism | Dipeptidyl-Peptidase IV Inhibitors - pharmacokinetics | Acidosis, Lactic - metabolism | Incretins - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Insulin - pharmacokinetics | Insulin - therapeutic use | Kidney Transplantation - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Pharmacokinetic and Pharmacodynamic Alterations in the Roux-en-Y Gastric Bypass Recipients
by Tandra, Sweta and Chalasani, Naga and Jones, David R and Mattar, Samer and Hall, Stephen D and Vuppalanchi, Raj
Annals of surgery, ISSN 0003-4932, 08/2013, Volume 258, Issue 2, pp. 262 - 269
furosemide | oral cocktail | CYP3A | gastric bypass | drug metabolism | Life Sciences & Biomedicine | Surgery | Science & Technology | Gastric Bypass | Diuretics - pharmacokinetics | Excitatory Amino Acid Antagonists - pharmacokinetics | Humans | Middle Aged | Tolbutamide - urine | Male | Caffeine - pharmacokinetics | Midazolam - urine | Anti-Ulcer Agents - pharmacokinetics | Young Adult | Hypoglycemic Agents - administration & dosage | Aged, 80 and over | Diuretics - urine | Diuretics - administration & dosage | Hypoglycemic Agents - pharmacokinetics | Administration, Oral | Furosemide - pharmacokinetics | Omeprazole - administration & dosage | Excitatory Amino Acid Antagonists - administration & dosage | Hypoglycemic Agents - urine | Omeprazole - urine | Central Nervous System Stimulants - pharmacokinetics | Midazolam - blood | Dextromethorphan - urine | Adolescent | GABA Modulators - urine | Central Nervous System Stimulants - urine | Dextromethorphan - administration & dosage | Furosemide - administration & dosage | Tolbutamide - administration & dosage | Tolbutamide - pharmacokinetics | Caffeine - administration & dosage | Omeprazole - blood | GABA Modulators - pharmacokinetics | Midazolam - administration & dosage | Anti-Ulcer Agents - blood | Chromatography, High Pressure Liquid | Case-Control Studies | Excitatory Amino Acid Antagonists - urine | Hypoglycemic Agents - blood | Tandem Mass Spectrometry | Biotransformation | Adult | Female | Dextromethorphan - pharmacokinetics | Furosemide - urine | Caffeine - urine | Caffeine - blood | GABA Modulators - administration & dosage | GABA Modulators - blood | Omeprazole - pharmacokinetics | Anti-Ulcer Agents - urine | Midazolam - pharmacokinetics | Anti-Ulcer Agents - administration & dosage | Dextromethorphan - blood | Excitatory Amino Acid Antagonists - blood | Tolbutamide - blood | Aged | Central Nervous System Stimulants - blood | Pharmacokinetics | Central Nervous System Stimulants - administration & dosage | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights